Skip to content

Effect of Panchagavya Ghrita Nasya in Vishada with special reference to Mild to Moderate Depression.

Randomized Control Trials of Panchagavya Ghrita Nasya in Vishada with special reference to Mild to Moderate Depression. - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/03/063884
Enrollment
114
Registered
2024-03-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G- Mental Health

Interventions

None listed

Sponsors

Dr Pramod Sakharam Mandalkar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients diagnosed as per the criteria for Mild and Moderate depression as per ICD-10, Indicated for Nasya Karma procedure, Patient is not allowed other medications for depression during study period

Exclusion criteria

Exclusion criteria: Patients below age 18 and above 50 years, Contraindicated for Nasya Karma, Patients with other psychiatric disorders and major depressive disorder, Patients with Chronic illness like Cancer, Hypertension, Diabetes Mellitus and Thyroid Disorders, Patients with suicidal tendency or thoughts and Organic Mood disorders, Chronic drug abuse, Chronic Alcoholic

Design outcomes

Primary

MeasureTime frame
To compare the effect of Panchagavya Ghrita Nasya and Hingwadi Ghrita Nasya in Vishada with special reference to Mild to Moderate Depression.Timepoint: 21 days

Secondary

MeasureTime frame
To review of Vishada according to Ayurved and Modern aspects. To review of Nasya Karma according to Ayurved and Modern aspects. To study the Adverse Drug Reaction if observed. To evaluate the probable mode of action of Panchagavya Ghrita Nasya.Timepoint: 2 Years

Countries

India

Contacts

Public ContactDr Alaknanda Kulkarni

Honorable Annasaheb Dange Ayurved Medical College and Post Graduate Research Center, Astha

vdpramod31@gmail.com9604633832

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026